PulseAugur
EN
LIVE 16:10:10

Vitestro's blood-drawing robot authorized for U.S. market

A new robotic system designed to draw blood has received authorization in the U.S. The device, developed by Vitestro, aims to automate the phlebotomy process. This technology is expected to become available in the United States soon. AI

IMPACT This technology could streamline medical procedures and potentially reduce human error in blood collection.

RANK_REASON The item discusses a new medical device that automates a specific task, fitting the 'tool' category.

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Vitestro's blood-drawing robot authorized for U.S. market

How we ranked this

Signal score
1 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The item discusses a new medical device that automates a specific task, fitting the 'tool' category.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
Same-day
Cluster formed today. Ranking reflects the current source set at time of score.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Amy Feldman, Forbes Staff ·

    A Robot That Can Draw Your Blood Is Coming To The U.S.

    This week’s edition of InnovationRx looks at Vitestro’s newly authorized robot, Italy’s $10 billion pharma family, this year’s Covid-19 vaccines and more.